Japanese #3 drugmaker Daiichi Sankyo is buying majority control of India's #1 pharma firm...
Japanese #3 drugmaker Daiichi Sankyo is buying majority control of India's #1 pharma firm Ranbaxy for up to $4.6B, a 31.4% premium. Keep an eye on Dr. Reddy's (RDY).
From other sites
at CNBC.com (Nov 6, 2014)
at CNBC.com (Jan 16, 2014)
at CNBC.com (May 14, 2013)
at CNBC.com (Oct 8, 2012)
at CNBC.com (Feb 17, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs